Physician profile
Luis Raul Lopez
NPI 1821148917
$4,376.30
in general payments reported to CMS, 2019-2025
33 companies · $303 in 2025
The $303 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $935 · 2020: $694 · 2021: $592 · 2022: $923 · 2023: $584 · 2024: $344 · 2025: $303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,231.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,231.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $588.67 | 2019-2025 | Jardiance |
| Sanofi-Aventis U.S. LLC | $552.01 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $309.89 | 2019-2025 | Farxiga |
| Abbvie INC. | $305.98 | 2019-2023 | |
| Glaxosmithkline, LLC. | $258.53 | 2020-2024 | Trelegy Ellipta, Arexvy |
| Abbott Laboratories | $258.44 | 2020-2025 | Proclaim, Assurity |
| Lilly USA, LLC | $254.31 | 2019-2025 | Jardiance, Zepbound, Mounjaro |
| Amgen INC. | $248.47 | 2019-2024 | Repatha, Otezla |
| Amarin Pharma, INC. | $217.24 | 2019-2020 | |
| Boston Scientific Corporation | $167.10 | 2021-2022 | |
| Abiomed | $148.27 | 2023 | Impella |
| Pfizer INC. | $121.60 | 2019-2024 | |
| Novo Nordisk INC | $91.93 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $86.42 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $82.94 | 2022-2025 | Gardasil 9, Capvaxive |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $81.94 | 2020 | |
| Seqirus USA INC | $71.55 | 2022-2023 | Flucelvax Quadrivalent, Fluad Quadrivalent |
| Bayer Healthcare Pharmaceuticals INC. | $54.30 | 2022-2025 | |
| Inspire Medical Systems, INC. | $51.78 | 2024-2025 | Inspire |
| Sumitomo Pharma America, INC. | $49.28 | 2024-2025 | Gemtesa |
| Exact Sciences Corporation | $49.11 | 2024-2025 | Cologuard Collection Kit |
| Medtronic, INC. | $46.28 | 2021-2025 | Symplicity G3 |
| Acell, INC. | $44.31 | 2020 | |
| Tolmar, INC. | $38.97 | 2023 | |
| Sanofi Pasteur INC. | $38.59 | 2020-2024 | |
| Qiagen, LLC | $27.08 | 2022 | |
| Novartis Pharmaceuticals Corporation | $23.48 | 2022 | |
| Hologic Sales and Service, LLC | $22.42 | 2025 | Aptima |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21.98 | 2024 | Lifevest |
| Ascend Therapeutics US, LLC | $18.00 | 2021 | |
| Almatica Pharma LLC | $15.78 | 2024 | Loreev Xr |
| Medtronic USA, INC. | $15.67 | 2019 | |
| Lucid Diagnostics INC. | $13.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Lopez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.